Therapeutic Sesamol Attenuates Monocrotaline-Induced Sinusoidal Obstruction Syndrome in Rats by Inhibiting Matrix Metalloproteinase-9

Cell Biochemistry and Biophysics

Volumn 61, Issue 2, 2011, Pages 327-336

  Periasamy, Srinivasan ^a   Hsu, Dur Zong ^a   Chen, Shin Yi ^a   Yang, Shan Shan ^a   Chandrasekaran, Victor Raj Mohan ^a   Liu, Ming Yie ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Kupffer cell; Laminin; Mast cell; Matrix metalloproteinase 9; Monocrotaline; Neutrophil; Sinusoidal obstruction syndrome

Indexed keywords

1,3 BENZODIOXOLE DERIVATIVE; COLLAGEN; GELATINASE B; LAMININ; MONOCROTALINE; PEROXIDASE; PHENOL DERIVATIVE; PROTEINASE INHIBITOR; SESAMOL; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; IMMUNOLOGY; INJURY; KUPFFER CELL; LIVER; LIVER VEIN OBSTRUCTION; MALE; MAST CELL; METABOLISM; NEUTROPHIL; RAT; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; BENZODIOXOLES; COLLAGEN; DOWN-REGULATION; HEPATIC VENO-OCCLUSIVE DISEASE; KUPFFER CELLS; LAMININ; LIVER; MALE; MAST CELLS; MATRIX METALLOPROTEINASE 9; MONOCROTALINE; NEUTROPHILS; PEROXIDASE; PHENOLS; PROTEASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE INHIBITOR OF METALLOPROTEINASE-1; UP-REGULATION;

RATTUS;

EID: 80955165973     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-011-9215-3     Document Type: Article

References (47)

1. Rubbia-Brandt, L., Audard, V., Sartoretti, P., Roth, A. D., Brezault, C., Le Charpentier, M., et al. (2004). Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Annals of Oncology, 15, 460-466.
2. Coppell, J. A., Brown, S. A., & Perry, D. J. (2003). Veno-occlusive disease: Cytokines, genetics, and haemostasis. Blood Reviews, 17, 63-70.
3. Deleve, L. D. (2007). Hepatic microvasculature in liver injury. Seminars in Liver Disease, 27, 390-400.
4. Baybutt, R. C., Rosales, C., Brady, H., & Molteni, A. (2002). Dietary fish oil protects against lung and liver inflammation and fibrosis in monocrotaline treated rats. Toxicology, 175, 1-13.
5. Stoyanova, I. I. (2004). Relevance of mast cells and hepatic lobule innervation to liver injury. Romanian Journal of Gastroenterology, 13, 203-209.
6. Fondevila, C., Shen, X. D., Duarte, S., Busuttil, R. W., & Coito, A. J. (2009). Cytoprotective effects of a cyclic RGD peptide in steatotic liver cold ischemia and reperfusion injury. American Journal of Transplantation, 9, 2240-2250.
7. Jaeschke, H. (2006). Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. American Journal of Physiology-Gastrointestinal and Liver Physiology, 290, G1083-G1088.
8. Campian, M. E., Hardziyenka, M., de Bruin, K., van Eck-Smit, B. L., de Bakker, J. M., Verberne, H. J., et al. (2010). Early inflammatory response during the development of right ventricular heart failure in a rat model. European Journal of Heart Failure, 12, 653-658.
9. Deleve, L. D., Wang, X., Tsai, J., Kanel, G., Strasberg, S., & Tokes, Z. A. (2003). Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition. Gastroenterology, 125, 882-890.
10. Gieling, R. G., Wallace, K., & Han, Y. P. (2009). Interleukin-1 participates in the progression from liver injury to fibrosis. American Journal of Physiology-Gastrointestinal and Liver Physiology, 296, 1324-1331.
11. Zhang, Y., Liu, P., Gao, X., Qian, W., & Xu, K. (2010). rAAV2-TGF-beta(3) decreases collagen synthesis and deposition in the liver of experimental hepatic fibrosis rat. Digestive Diseases and Sciences, 55, 2821-2830.
12. Coussens, L. M., & Werb, Z. (2001). Inflammatory cells and cancer: Think different! Journal of Experimental Medicine, 193, F23-F26.
13. Coussens, L. M., Tinkle, C. L., Hanahan, D., & Werb, Z. (2000). MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell, 103, 481-490.
14. Narita, M., Hatano, E., Tamaki, N., Yamanaka, K., Yanagida, A., Nagata, H., et al. (2009). Dai-kenchu-to attenuates rat sinusoidal obstruction syndrome by inhibiting the accumulation of neutrophils in the liver. Journal of Gastroenterology and Hepatology, 24, 1051-1057.
15. Heissig, B., Rafii, S., Akiyama, H., Ohki, Y., Sato, Y., Rafael, T., et al. (2005). Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization. Journal of Experimental Medicine, 202, 739-750.
16. Heissig, B., Nishida, C., Tashiro, Y., Sato, Y., Ishihara, M., Ohki, M., et al. (2010). Role of neutrophil-derived matrix metalloproteinase-9 in tissue regeneration. Histology and Histopathology, 25, 765-770.
17. De Leve, L. D., Ito, Y., Bethea, N. W., McCuskey, M. K., Wang, X., & McCuskey, R. S. (2003). Embolization by sinusoidal lining cell obstructs the microcirculation in rat sinusoidal obstruction syndrome. American Journal of Physiology-Gastrointestinal and Liver Physiology, 284, G1045-G1052.
18. Fukuda, Y., Osawa, T., Namiki, M., & Ozaki, T. (1985). Studies on antioxidative substances in sesame seed. Agricultural and Biological Chemistry, 49, 301-306.
19. Fukuda, Y., Osawa, T., & Namiki, M. (1994). Chemistry of lignan antioxidants in sesame seed and oil. In C. T. Ho, T. Osawa, M. T. Huang, R. T. Rosen (Eds.), Food phytochemicals for cancer prevention II: Teas, spices and herbs, Vol 547 (pp. 264-274). Washington, DC: ACS Symposium Series.
20. Namiki, M. (1995). The chemistry and physiological function of sesame. Food Reviews International, 11, 281-329.
21. White, J. P. (1992). Fatty acids in oil seeds. Fatty acids in foods and their health applications (pp. 237-262). New York, NY: Dekker M. Incorporated.
22. Fukuda, Y. (1990). Food chemical studies on the antioxidants in sesame seed. Nippon Shokuhin Kogyo Gakkaishi, 37, 484-492.
23. Hsu, D. Z., Li, Y. H., Chu, P. Y., Chien, S. P., Chuang, Y. C., & Liu, M. Y. (2006). Attenuation of endotoxin-induced oxidative stress and multiple organ injury by 3, 4-methylenedioxyphenol in rats. Shock, 25, 300-305.
24. Hsu, D. Z., Chien, S. P., Chen, K. T., & Liu, M. Y. (2007). The effect of sesamol on systemic oxidative stress and hepatic dysfunction in acutely iron-intoxicated mice. Shock, 28, 596-601.
25. Periasamy, S., Mo, F. E., Chen, S. Y., Chang, C. C., & Liu, M. Y. (2011). Sesamol attenuates isoproterenol-induced acute myocardial infarction via inhibition of matrix metalloproteinase-2 and -9 expression in rats. Cellular Physiology and Biochemistry, 27, 273-280.
26. Chu, P. Y., Chien, S. P., Hsu, D. Z., & Liu, M. Y. (2010). Protective effect of sesamol on the pulmonary inflammatory response and lung injury in endotoxemic rats. Food and Chemical Toxicology, 48, 1821-1826.
27. Chu, P. Y., Hsu, D. Z., Hsu, P. Y., & Liu, M. Y. (2010). Sesamol down-regulates the lipopolysaccharide-induced inflammatory response by inhibiting nuclear factor-kappa B activation. Innate Immunity, 16, 333-339.
28. Kuhad, A., Sachdeva, A. K., & Chopra, K. (2009). Attenuation of renoinflammatory cascade in experimental model of diabetic nephropathy by sesamol. Journal of Agriculture and Food Chemistry, 57, 6123-6128.
29. Hsu, D. Z., Chen, K. T., Li, Y. H., Chuang, Y. C., & Liu, M. Y. (2006). Sesamol delays mortality and attenuates hepatic injury after cecal ligation and puncture in rats: Role of oxidative stress. Shock, 25, 528-532.
30. Hsu, D. Z., Chu, P. Y., Li, Y. H., & Liu, M. Y. (2008). Sesamol attenuates diclofenac-induced acute gastric mucosal injury via its cyclooxygenase-independent antioxidative effect in rats. Shock, 30, 456-462.
31. Geetha, T., Rohit, B., & Pal, K. I. (2009). Sesamol: An efficient antioxidant with potential therapeutic benefits. Medicinal Chemistry, 5, 367-371.
32. Hsu, D. Z., Wan, C. H., Hsu, H. F., Lin, Y. M., & Liu, M. Y. (2008). The prophylactic protective effect of sesamol against ferric-nitrilotriacetate-induced acute renal injury in mice. Food and Chemical Toxicology, 46, 2736-2741.
33. Shenoy, R. R., Sudheendra, A. T., Nayak, P. G., Paul, P., Kutty, N. G., & Rao, C. M. (2011). Normal and delayed wound healing is improved by sesamol, an active constituent of Sesamum indicum (L.) in albino rats. Journal of Ethnopharmacology, 133, 608-612.
34. Hsu, D. Z., Chu, P. Y., & Liu, M. Y. (2009). The non-peptide chemical 3, 4-methylenedioxyphenol blocked lipopolysaccharide (LPS) from binding to LPS-binding protein and inhibited pro-inflammatory cytokines. Innate Immunity, 15, 380-385.
35. Kapadia, G. J., Azuine, M. A., Tokuda, H., Takasaki, M., Mukainaka, T., Konoshima, T., et al. (2002). Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis. Pharmacological Research, 45, 499-505.
36. Periasamy, S., Chen, S. Y., Hsu, D. Z., & Liu, M. Y. (2010). Comments on Vennila and Pugalendi. Vennila L, Pugalendi KV (2010) Protective effect of sesamol against myocardial infarction caused by isoproterenol in Wistar rats. Redox Rep 2010; 15: 36-42. Redox Report, 15, 288-289.
37. Shah, M. S., Jeevangi, N. K., Joshi, A., & Khattry, N. (2009). Late-onset hepatic veno-occlusive disease post autologous peripheral stem cell transplantation successfully treated with oral defibrotide. Journal of Cancer Research and Therapeutics, 5, 312-314.
38. Richardson, P. G., Soiffer, R. J., Antin, J. H., Uno, H., Jin, Z., Kurtzberg, J., et al. (2010). Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: A multicenter, randomized, dose-finding trial. Biology of Blood and Marrow Transplantation, 16, 1005-1017.
39. Chen, I. L., Yang, S. N., Hsiao, C. C., Wu, K. S., & Sheen, J. M. (2008). Treatment with high-dose methylprednisolone for hepatic veno-occlusive disease in a child with rhabdomyosarcoma. Pediatrics and Neonatology, 49, 141-144.
40. Al Beihany, A., Al Omar, H., Sahovic, E., Chaudhri, N., Al Mohareb, F., Al Sharif, F., et al. (2008). Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short course of methylprednisolone. Bone Marrow Transplantation, 41, 287-291.
41. Chevallier, P., Prebet, T., Turlure, P., Hunault, M., Vigouroux, S., Harousseau, J. L., et al. (2010). Prior treatment with gemtuzumab ozogamicin and the risk of veno-occlusive disease after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplantation, 45, 165-170.
42. Sakaguchi, H., Watanabe, N., Muramatsu, H., Doisaki, S., Yoshida, N., Matsumoto, K., et al. (2010). Danaparoid as the prophylaxis for hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation in childhood hematological malignancy. Pediatric Blood & Cancer, 55, 1118-1125.
43. Klinger, M., Eipeldauer, S., Hacker, S., Herberger, B., Tamandl, D., Dorfmeister, M., et al. (2009). Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases. European Journal of Surgical Oncology, 35, 515-520.
44. Rubbia-Brandt, L., Lauwers, G. Y., Wang, H., Majno, P. E., Tanabe, K., Zhu, A. X., et al. (2010). Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology, 56, 430-439.
45. Palmer, K. J., & Goa, K. L. (1993). Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders. Drugs, 45, 259-294.
46. Deng, F., Lu, L., Zhang, Q., Hu, B., Wang, S. J., & Huang, N. (2010). Henoch-Schönlein purpura in childhood: Treatment and prognosis. Analysis of 425 cases over a 5-year period. Clinical Rheumatology, 29, 369-374.
47. Risch, L., Huber, A. R., & Schmugge, M. (2006). Diagnosis and treatment of heparin-induced thrombocytopenia in neonates and children. Thrombosis Research, 118, 123-135.